Lung cancer screening: the way forward.
Lung cancer screening: the way forward.
复制标题
肺癌筛查:前进的方向。
DOI:
10.1038/sj.bjc.6604509
复制
发表时间:
2008-08-19
影响因子:
8.8
通讯作者:
Duffy, S. W.
中科院分区:
文献类型:
--
作者:
Field, J. K.;Duffy, S. W.
To take lung cancer screening into national programmes, we first have to answer the question whether low-dose computed tomography (LDCT) screening and treatment of early lesions will decrease lung cancer mortality compared with a control group, to accurately estimate the balance of benefits and harms, and to determine the cost-effectiveness of the intervention.
登录
查看更多内容
DOI:
10.1016/s0197-2456(00)00097-0
发表时间:
2000-12-01
期刊:
CONTROLLED CLINICAL TRIALS
影响因子:
--
作者:
Gohagan, JK;Prorok, PC;Kramer, BS
通讯作者:
Kramer, BS
影响因子:
10
作者:
MacRedmond, R;Logan, PM;Costello, RW
通讯作者:
Costello, RW
影响因子:
19.7
作者:
NAIDICH, DP;MARSHALL, CH;MCCAULEY, DI
通讯作者:
MCCAULEY, DI
DOI:
10.1097/01243894-200606000-00020
发表时间:
2006-06-01
期刊:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
影响因子:
--
作者:
Field, J K;Smith, R A;Mulshine, J L
通讯作者:
Mulshine, J L
影响因子:
158.5
作者:
Henschke, Claudia I.;Yankelevitz, David F.;Miettinen, Olli S.
通讯作者:
Miettinen, Olli S.